| 1 | Study | 0.91% | |
| 2 | Cancer | 0.91% | |
| 3 | Health | 0.68% | |
| 4 | Linked | 0.6% | |
| 5 | Report | 0.6% | |
| 6 | Risk | 0.53% | |
| 7 | New | 0.53% | |
| 8 | Case | 0.53% | |
| 9 | Patients | 0.45% | |
| 10 | Medicina | 0.45% | |
| 11 | COVID-19 | 0.45% | |
| 12 | County | 0.45% | |
| 13 | Disease | 0.38% | |
| 14 | Trump | 0.38% | |
| 15 | Forecast | 0.38% | |
| 16 | Covid | 0.3% | |
| 17 | CDC | 0.3% | |
| 18 | Use | 0.3% | |
| 19 | May | 0.3% | |
| 20 | Blood | 0.3% | |
| 21 | Mexico | 0.3% | |
| 22 | Anvisa | 0.3% | |
| 23 | Diabetes | 0.3% | |
| 24 | Syndrome | 0.3% | |
| 25 | AI | 0.3% | |
| 26 | Measles | 0.23% | |
| 27 | Medico | 0.23% | |
| 28 | Brain | 0.23% | |
| 29 | Drug | 0.23% | |
| 30 | Over | 0.23% | |
| 31 | About | 0.23% | |
| 32 | Outbreaks | 0.23% | |
| 33 | Type | 0.23% | |
| 34 | Mpox | 0.23% | |
| 35 | Immune | 0.23% | |
| 36 | Severe | 0.23% | |
| 37 | Review | 0.23% | |
| 38 | Cannabis | 0.23% | |
| 39 | Cells | 0.23% | |
| 40 | Medicine | 0.23% | |
| 41 | Pandemic | 0.23% | |
| 42 | University | 0.23% | |
| 43 | Vaccines | 0.23% | |
| 44 | Trumps | 0.23% | |
| 45 | Diagnosis | 0.23% | |
| 46 | First | 0.23% | |
| 47 | Colorectal | 0.23% | |
| 48 | Children | 0.23% | |
| 49 | Patient | 0.23% | |
| 50 | Poor | 0.23% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
GSK: 3-Year Efficacy Data for Arexvy in Older Adults Published in Lancet Respiratory Medicine
Patient Care Online
2025-04-17 21:32:16